Venture Life Group

Venture Life Group (LON:VLG) anticipates **nearly sixfold profit growth** this year following a restructured business model. The company’s market capitalization stands at **£81 million**, with shares rising from a May low of **54p to 67.50p**, nearing their yearly high of **72p**. The group, headquartered in Bracknell, is preparing to release its **Final Results on September 29**, which could influence investor sentiment.

Sep 2026UK Investor MagazineNews article

ITM Power secures selection for expansion in Asia as part of a strategic move. Separately, Venture Life sells its manufacturing operations, though no buyer or terms are disclosed. Belluscura’s shares rise 54.6% after announcing a strategic review, though the company faces a working capital shortage with $1m in cash and $790k in debt as of April 2025.

May 2025UK Investor MagazineNews article

Venture Life Group trades at just **9 times current-year earnings** and **7 times prospective earnings**, according to its latest interim results. Brokers project a **52% earnings uplift**, reinforcing the company’s undervaluation relative to market expectations. The stock is positioned as a high-potential ‘venture’ play despite its lower multiple.

Oct 2024UK Investor MagazineNews article

Venture Life Group acquires HL Healthcare, owner of medical products Earol, EarolSwim, and Sterinase, for £13 million. The deal includes £3 million contingent on 2022-23 revenue performance, with the acquired products reporting £1.7 million in EBITDA for 2021-22. Venture Life projects a 2022 pre-tax profit of £946,000, potentially rising above £4 million in 2023. The acquisition follows a 17.9% share price increase to 31.25p.

Dec 2022UK Investor MagazineNews article